Stock price performance of Cara Therapeutics, Inc. is analyzed for various periods using several stock trading signals. In this case, The stock price has rallied 76.38% in the past 12 Weeks , but analyzing the 6 month charts for the stock , the price continues to stay positive and keep the rally at 181.73% . Looking at the past 52 week period, the stock price is up at 111.29% . Relative price strength is a important factor used by wealth management firms while investing in stocks because the indicator compares the stock performance with the overall market. The relative price strength of Cara Therapeutics, Inc. has a positive value of 49.36 compared to overall market. For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a 20-day Moving Average of 25.15% and the 50-Day Moving Average is 34.54%.The 200 Day SMA reached 88.45%
Based on the Stock Research Cara Therapeutics, Inc. Relative Strength Index signal is in over bought territory with a range of 80.39. Cara Therapeutics, Inc. (NASDAQ:CARA) has climbed 19.96% in the past week and advanced 61.97% in the last 4 weeks. In the past week, the company has outperformed the S&P 500 by 19.81% and the outperformance has advanced to 60.52% for the last 4 weeks period.
Company has reported several Insider transactions to the SEC, on Apr 20, 2016, Frederique Ph.d. Menzaghi (VP-Research & Development) sold 6,000 shares at 9.00 per share price.On Jan 27, 2016, Michael E Lewis (Chief Scientific Advisor) sold 7,262 shares at 10.93 per share price.On Jan 12, 2016, Dean Slagel (director) sold 44,000 shares at 17.00 per share price.
Cara Therapeutics Inc Last issued its quarterly earnings results on Nov 3, 2016. The company reported $-0.42 EPS for the quarter, beating the analyst consensus estimate by $ 0.05. Analyst had a consensus of $-0.47.Analysts expectations of $ .09.During the same quarter in the previous year, the company posted $-0.19 EPS.
Cara Therapeutics, Inc. (NASDAQ:CARA) : On Friday heightened volatility was witnessed in Cara Therapeutics, Inc. (NASDAQ:CARA) which led to swings in the share price. The stock opened for trading at $16.22 and hit $16.75 on the upside , eventually ending the session at $16.65, with a gain of 5.11% or 0.81 points. The heightened volatility saw the trading volume jump to 2,522,041 shares. The 52-week high of the share price is $17.2 and the company has a market cap of $454 million. The 52-week low of the share price is at $4.26 .
Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.